Safety of fluoxetine use in children and adolescents: a disproportionality analysis of the Food and Drug Administration Adverse Event Reporting System (FAERS) database

被引：0
|
作者：
Iole N. Christodoulos
Te-yuan Chyou
Prasad S. Nishtala
机构：
[1] University of Bath,Department of Pharmacy & Pharmacology
[2] University of Otago,Department of Biochemistry
来源：
European Journal of Clinical Pharmacology | 2020年 / 76卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1775 / 1776
页数：1
相关论文
共 50 条
  • [1] Safety of fluoxetine use in children and adolescents: a disproportionality analysis of the Food and Drug Administration Adverse Event Reporting System (FAERS) database
    Christodoulos, Iole N.
    Chyou, Te-yuan
    Nishtala, Prasad S.
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2020, 76 (12) : 1775 - 1776
  • [2] Safety of propofol use in children and adolescents: A disproportionality analysis of the Food and Drug Administration adverse event reporting system (FAERS)
    Li, Hailong
    Bo, Zhenyan
    Zhang, Lingli
    [J]. PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2021, 30 : 334 - 335
  • [3] Novel Adverse Events of Iloperidone: A Disproportionality Analysis in US Food and Drug Administration Adverse Event Reporting System (FAERS) Database
    Subeesh, Viswam
    Maheswari, Eswaran
    Singh, Hemendra
    Beulah, Thomas Elsa
    Swaroop, Ann Mary
    [J]. CURRENT DRUG SAFETY, 2019, 14 (01) : 21 - 26
  • [4] Pancreatitis Associated With Teduglutide: A Disproportionality Analysis via the Food and Drug Administration Adverse Event Reporting System (FAERS) Database
    Gu, Joyce H.
    Sheingold, Zachary
    Samarneh, Mark
    [J]. CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (08)
  • [5] Safety of Marketed Cancer Supportive Care Biosimilars in the US: A Disproportionality Analysis Using the Food and Drug Administration Adverse Event Reporting System (FAERS) Database
    Tanni, Kaniz Afroz
    Truong, Cong Bang
    Almahasis, Sura
    Qian, Jingjing
    [J]. BIODRUGS, 2021, 35 (02) : 239 - 254
  • [6] Safety of Marketed Cancer Supportive Care Biosimilars in the US: A Disproportionality Analysis Using the Food and Drug Administration Adverse Event Reporting System (FAERS) Database
    Kaniz Afroz Tanni
    Cong Bang Truong
    Sura Almahasis
    Jingjing Qian
    [J]. BioDrugs, 2021, 35 : 239 - 254
  • [7] Antibiotics-associated pseudomembranous colitis: a disproportionality analysis of the US food and drug administration adverse event reporting system (FAERS) database
    Chen, Jinhua
    Yu, Weijiang
    Zhang, Wancun
    Sun, Cuicui
    Zhang, Wenzhou
    [J]. EXPERT OPINION ON DRUG SAFETY, 2024,
  • [8] Safety of marketed biosimilar monoclonal antibody cancer treatments in the US: a disproportionality analysis using the food and drug administration adverse event reporting system (FAERS) database
    Xue, Xiangzhong
    Qian, Jingjing
    [J]. EXPERT OPINION ON DRUG SAFETY, 2024,
  • [9] Comment on: "Safety of Marketed Cancer Supportive Care Biosimilars in the US: A Disproportionality Analysis Using the Food and Drug Administration Adverse Event Reporting System (FAERS) Database"
    Putzke, Joerg
    Haughie, Scott
    Zou, Kelly H.
    Ranganna, Gopinath M.
    [J]. BIODRUGS, 2021, 35 (03) : 373 - 374
  • [10] US Food and Drug Administration Safety Advisories and Reporting to the Adverse Event Reporting System (FAERS)
    Thomas J. Moore
    Richard L. Morrow
    Colin R. Dormuth
    Barbara Mintzes
    [J]. Pharmaceutical Medicine, 2020, 34 : 135 - 140
12345